Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1993-03-05
1995-10-10
Robinson, Douglas W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 273, 536 276, 536 277, 544264, 546118, C07H 1916
Patent
active
054571910
ABSTRACT:
This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of "antisense" agents, agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The 3-deazapurine-containing compounds of this invention can be useful for modulating the activity of RNA when incorporated into oligonucleotides. Oligonucleotides and their analogs are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins and cleaving RNA in site specific fashions.
REFERENCES:
patent: 3919193 (1975-11-01), Mian et al.
patent: 4381344 (1983-04-01), Rideout et al.
patent: 4481197 (1984-11-01), Rideout et al.
The Chemistry of Heterocyclic Compounds, A. Weissberger, Ed., Imidazole and Derivatives, Part 1, Interscience, N.Y. (1953).
Cook, et al. J. Am. Chem. Soc., 1975, 97, 2916.
Cook, et al., Synthesis and Antiviral and Enzymatic Studies of Certain 3-Deazaguaines and Their Imidazolecarboxamide Precursors, J. Med. Chem., 1978, 21, 1212.
Greene and Wuts, Protective Groups in Organic Synthesis, (2nd edition, John Wiley & Sons, New York, 1991.
Stein, et al., Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review, Cancer Research 1988, 48, 2659-2668.
Walder, Genes & Development, 1988, 2 502-504.
Marcus-Sekura, Techniques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression, Anal. Biochemistry, 1988, 172, 289-295.
Zon, Synthesis of Backbone-Modified DNA Analogues for Biological Applications, J. Protein Chemistry, 1987, 6, 131-145.
Zon, Oligonucleotide Analogues as Potential Chemotherapeutic Agents, Pharmaceutical Res., 1988, 5, 539-549.
Van der Krol, et al., Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences, BioTechniques, 1988, 6, 958-973.
Loose-Mitchell-TIPS, 1988, 9, 45-47.
Miller, et al., A new approach to chemotherapy based on molecular biology and nucleic acid chemistry. Matagen (masking tape for gene expression), Anti-Cancer Drug Design, 1987, 2, 117-128.
Walder et al., Role of RNase H in hybrid-arrested translation by antisense oligonucleotides, Proc. Natl. Acad. Sci., U.S.A., 1988, 85, 5011-5015.
Stein, et al., Physiochemical properties of phosphorothioate olgodeoxynucleotides, Nucleic Acids Research, 1988, 16, 3209-3221.
Burman, et al., IV: Studies on biological activities and mechanism of action of 3-deazaguaine nucleosides, Chem. Scripta, 1986, 26, 155-159.
Hartman, et al., J. Labelled Compd. Radiopharm., 1985, 23, 35.
Revankar, et al., Synthesis and Antiviral/Antitumor Activities of Certain 3-Deazaguaine Nucleosides and Nucletides, J. Med. Chem., 1984, 27, 1389.
Saengner, Principles of Nucleic Acid Structure, Cantor, C. R., Ed., Springer-Verlag, New York, 1983.
Saran, et al., Molecular Orbital Studies on the Structure of Nucleoside Analogs. IV. Conformation of 3-Deazapurine Nucleosides, Int. J. Quantum Chem. 1984 25, 743.
Miles, et al., A Conformational Basis for the Selective Action of Ara-Adenine, J. Theor. Biol. 1977, 67, 499.
Caruthers, Oligonucleotides, Antisense Inhibitors of Gene Expression, pp. 7-24, J. S. Cohen, ed. (CRC Press, Inc. Boco Raton, Fla., 1989).
Beaucage et al., Deoxynucleoside Phosphoramidites-A New Class of Key Intermediates for Deoxypolynucleotide Synthesis, Tetrahedron Letters, 1981, 22, 1859-1862.
Veber and Hirschmann, et al., Isonicotinyloxycarbonyl, a Novel Amino Protecting Group for Peptide Synthesis, J. Org. Chem. 1977, 42, 3286.
Atherton, et al., The Peptides, Gross and Meienhofer, Eds, Academic Press; New York, 1983; vol. 9 pp. 1-38.
Journal of Medicinal Chemistry, vol. 27, p. 1389 (1984).
Journal of Medicinal Chemistry, vol. 21, p. 1212 (1978).
Beaucage, 3H-1, 2-Benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the Solid-Phase Synthesis of Oligeodeoxyribonucleoside Phosphorothioates, J. Am. Chem. Soc., vol. 112, pp. 1253-1255 (1990).
Rosenmeyer, et al., Syn-Anti Conformational Analysis of Regular and Modified Nucleosides by 1D .sup.1 H NOE Difference Spectroscopy: A Simple Graphical Method Based on Conformationally Rigid Molecules, J. Org. Chem., 1990, 55, 5784.
Cook, et al., Synthesis of 7-and 9-.beta.-D-Ribofuranosides of 3-Deaza-6-thioguanine and 3-Deaza-2, 6-diaminopurine by a Novel Ring Closure of 4(5)-Cyano-5(4)-cyanomethylimidazole .beta.-D-Ribofuranosiedes, J. Org. Chem. 1978, 43, 289.
M. S. Motawai et al., A New Route to 2', 3'-Dideoxycytidine, Liebigs Ann. Chem., 1990, 599-602.
Pretsch, et al., Spectral Data for Structure Determination of Organic Compounds, 2nd edition, 1989, p. H-15.
Acevedo Oscar L.
Andrews Robert S.
Cook P. Dan
ISIS Pharmaceuticals Inc.
Robinson Douglas W.
Wilson J. Oliver
LandOfFree
3-deazapurines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-deazapurines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-deazapurines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2311049